[Form 4] Apple Inc. Insider Trading Activity

Rhea-AI Filing Summary

Deirdre O'Brien, identified as Senior Vice President and an officer of Apple Inc. (AAPL), reported the acquisition of two restricted stock unit awards on 09/28/2025. Each award covers 48,932 restricted stock units (RSUs); one set vests in three equal installments on April 1, 2028, April 1, 2029 and April 1, 2030, and the other is a performance-based RSU with a target of 48,932 units that may vest between 0% and 200% based on Apple’s relative total shareholder return for fiscal years 2026–2028, with a scheduled vest date of October 1, 2028. Each RSU represents the right to receive one share at settlement; the reported price is $0 as these are awards, and each line shows 48,932 shares beneficially owned following the transactions.

Positive

• Two equity awards were granted to Senior Vice President Deirdre O'Brien (each for 48,932 RSUs), explicitly aligning compensation with future performance and retention
• Performance award includes a defined payout range (0%–200%) tied to relative total shareholder return over fiscal 2026–2028, linking pay to shareholder outcomes

Negative

• No negative events or dispositions are reported in this Form 4; the filing only records grant of RSUs
• Form does not disclose aggregate pre-existing holdings beyond the reported awards, so total insider ownership is not shown

Insights

Compensation/Corporate Governance Analyst

TL;DR: Officer received time-based and performance-based RSU awards tying compensation to retention and multi-year shareholder performance.

The filing documents two awards of 48,932 RSUs each for Senior Vice President Deirdre O'Brien, granted 09/28/2025. One award vests in three equal tranches in April 2028–2030, supporting executive retention. The other is a performance-based award with a target equal to 48,932 units and a payout range of 0%–200% tied to relative total shareholder return over fiscal 2026–2028, aligning a meaningful portion of compensation with multi-year shareholder outcomes. The filing reports settlement mechanics (one share per RSU) and shows the awards at grant value (price $0) as equity compensation granted, with no additional holdings disclosed beyond the reported awards.

Securities/Insider Filings Specialist

TL;DR: Form 4 correctly discloses grant details, vesting schedules, and performance metric range; no cash purchase was involved.

The statement of changes in beneficial ownership shows acquisitions reported as awards (price listed as $0) with specified vesting dates and performance measurement period. The report is filed individually and includes an attorney-in-fact signature dated 09/30/2025. The Form 4 entries specify the number of units and the settlement conversion (one RSU per share), meeting disclosure expectations for Section 16 reporting. No exercise, sale, or cash transactions are reported in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

O'BRIEN DEIRDRE

(Last) (First) (Middle)

ONE APPLE PARK WAY

(Street)

CUPERTINO CA 95014

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Apple Inc. [ AAPL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
09/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/28/2025		A		48,932		(2)	(2)	Common Stock	48,932	$0	48,932	D
Restricted Stock Unit	(1)	09/28/2025		A		48,932		(3)	(3)	Common Stock	48,932	$0	48,932	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

2. These restricted stock units are scheduled to settle as to one-third of the units on each of April 1, 2028, April 1, 2029, and April 1, 2030, subject to the terms and conditions of the underlying award agreement.

3. These performance-based restricted stock units are scheduled to vest on October 1, 2028, subject to the terms and conditions of the underlying award agreement. The "target" number of restricted stock units is reported. Between 0% and 200% of the target number of units may vest based on Apple's relative total shareholder return from the first day of Apple's fiscal year 2026 and ending with the last day of Apple's fiscal year 2028.

Remarks:

	/s/ Sam Whittington, Attorney-in-Fact for Deirdre O'Brien	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Deirdre O'Brien report on Form 4 for AAPL?

The Form 4 reports two restricted stock unit awards granted on 09/28/2025, each covering 48,932 RSUs.

What are the vesting schedules for the RSUs reported by Deirdre O'Brien?

One award vests in three equal tranches on April 1, 2028, April 1, 2029, and April 1, 2030. The performance-based award has a scheduled vest date of October 1, 2028 and vests based on performance.

How is the performance RSU grant determined for AAPL's Form 4?

The performance RSU grant is reported at a target of 48,932 units and may vest between 0% and 200% based on Apple’s relative total shareholder return from fiscal 2026 through fiscal 2028.

Did the Form 4 report any cash purchase or sale of Apple shares by Deirdre O'Brien?

No. The filing reports equity awards (RSUs) with an indicated price of $0; there are no cash purchases or sales disclosed.

When was the Form 4 signed and filed for this disclosure?

The signature on the Form 4 is dated 09/30/2025, signed by an attorney-in-fact for Deirdre O'Brien.